Literature DB >> 19138832

Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival.

T Lehnert1, S Cardona, U Hinz, F Willeke, G Mechtersheimer, M Treiber, C Herfarth, M W Buechler, M H M Schwarzbach.   

Abstract

AIM: To evaluate local control for long-term prognosis in retroperitoneal soft-tissue sarcoma (primary tumors (PT) and local recurrence (LR)).
METHODS: A total of 110 patients underwent surgery between 1988 and 2002. Prospectively gathered clinicopathological data were analyzed. Kaplan-Meier estimations and Cox regression analyses were performed.
RESULTS: Resectability was 90%, being comparable for PT (n=71) and LR (n=39). Morbidity, mortality, blood loss, and operation time did not differ for PT or LR (24% vs. 31%, p=0.41; 7.0% vs. 5.1%, p=1.0; 1000 ml vs. 1500 ml, p=0.17; 240 min vs. 255 min, p=0.13). Hospitalization was comparable in both groups (median, 12 days (PT) and 13 days (LR)). Follow-up was 89 months (median, IQR 37-112 months). Local 3- and 5-year control rates after complete resection of PT were 66% and 59% (19% and 9% for LR, p<0.001). The mean number of operations were 1.4 for PT and 2.4 for LR (p=0.0047). The 5-year survival rates after complete resection were 51% for PT and 43% for LR (p=0.39). The 5-year survival rates were 65%, 4%, and 0% for complete resection, incomplete resection, and exploration, respectively (p<0.001). Multivariate analysis showed high-grade and blood loss with a poor prognosis.
CONCLUSIONS: Comparable resectability rates and perioperative outcome were observed for surgery of PT and LR. Consequent reoperation leads to respectable long-term survival rates after resection of LR. The prognosis in retroperitoneal sarcomas varies significantly according to resectability, grade and blood loss.

Entities:  

Mesh:

Year:  2009        PMID: 19138832     DOI: 10.1016/j.ejso.2008.11.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  34 in total

1.  Long-term results of primary and secondary resections in patients with retroperitoneal soft tissue sarcoma.

Authors:  Alexandra M Koenig; Matthias Reeh; Christoph M Burdelski; Claudia Wengert; Karim A Gawad; Jakob R Izbicki; Maximilian Bockhorn
Journal:  Langenbecks Arch Surg       Date:  2012-03-10       Impact factor: 3.445

Review 2.  [Vascular replacement in abdominal tumor surgery].

Authors:  A Mehrabi; P Houben; N Attigah; D Böckler; M W Büchler; J Weitz
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

3.  Gastric tube reconstruction reduces postoperative gastroesophageal reflux in adenocarcinoma of esophagogastric junction.

Authors:  Xiu-Feng Chen; Bo Zhang; Zhi-Xin Chen; Jian-Kun Hu; Bin Dai; Fang Wang; Hong-Xin Yang; Jia-Ping Chen
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

Review 4.  Synthetic Biomaterials from Metabolically Derived Synthons.

Authors:  Nicole G Ricapito; Cynthia Ghobril; Heng Zhang; Mark W Grinstaff; David Putnam
Journal:  Chem Rev       Date:  2016-01-29       Impact factor: 60.622

Review 5.  Retroperitoneal tumours: review of management.

Authors:  Dirk C Strauss; Andrew J Hayes; J Meirion Thomas
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

6.  Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival.

Authors:  Jinsoo Rhu; Chan Woo Cho; Kyo Won Lee; Hyojun Park; Jae Berm Park; Yoon-La Choi; Sung Joo Kim
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

Review 7.  [Biopsy of musculoskeletal tumors : Complications and avoidable errors].

Authors:  D Winkler; H Fritzsche; K-D Schaser; C Hofbauer
Journal:  Orthopade       Date:  2020-02       Impact factor: 1.087

8.  Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group.

Authors: 
Journal:  Ann Surg Oncol       Date:  2016-08-01       Impact factor: 5.344

9.  Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates.

Authors:  Koichiro Yamakado; Akihiko Matsumine; Tomoki Nakamura; Atsuhiro Nakatsuka; Haruyuki Takaki; Takao Matsubara; Kunihiro Asanuma; Akihiro Sudo; Yoshiki Sugimura; Hajime Sakuma
Journal:  Int J Clin Oncol       Date:  2013-11-28       Impact factor: 3.402

10.  Retroperitoneal or mesenteric primary liposarcoma: clinical and prognostic evaluations on five cases.

Authors:  L Rosato; L Panier Suffat; L Bertotti; P Perino; E Comello; G Mondini
Journal:  G Chir       Date:  2018 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.